INIFY® Prostate Screening is an AI-powered tool that provides pathologists with valuable decision support when identifying cancer in prostate biopsies. Exploring the advantages of today’s digital technology in whole new ways, and drawing on the very latest breakthroughs in deep learning, INIFY Prostate Screening empowers pathologists faced with today’s ever-increasing workload. It makes room for smarter, more accurate and faster decisions, decisions, is proven to be robust across different labs and scanners, and is adaptable to different workflows and user needs. INIFY Prostate Screening builds on the resilient foundation of innovation, technical know-how and professionalism that has been a trademark of ContextVision for the last 30 years.
INIFY® Prostate Screening

2020-06-29
We are proud to announce that INIFY Prostate Screening has been granted CE mark status, and is now available for routine clinical use within the European Union.